Pharma Marketing Network offers its members a free monthly newsletter, an online discussion forum, and other benefits
We accept advertising relevant to the interests of our members.
For more information, see:
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
The Leading Online Resource for Pharmaceutical Marketers
Pharma Marketing News | Subscribe | Online Discussion Forum | Pharma Marketing Roundtable
Reports | Resources/Links | Glossary | Case Studies | Surveys | Pharma Marketing Blog
Pharma Marketing Vendor Directory | Conference Calendar | Pharma Jobs
Advertising Information | FAQs | About Us | Privacy Policy
Survey About CHC's Petition to FDA on DTC and Risk Communication
This survey is closed.
Survey began 31 March 2006
Survey began 20 November 2006
THE ISSUESurvey Results:Simplifying Risk Statements in DTC Advertising
The Coalition for Healthcare Communication (CHC) -- comprised of major advertising, marketing and PR organizations, including the American Association of Advertising Agencies, the Association of National Advertisers, and the Public Relations Society of America -- filed a Citizen Petition with the Food and Drug Administration recently asking the FDA to formulate new rules governing consumer advertising of prescription drugs (see "Coalition for Healthcare Communication Seeks New Prescription Drug Advertising Rules").
The CHC's proposal calls for the elimination of specific risk information in print, broadcast, and Internet-based DTC (direct to consumer) advertising.
CHC suggests the following as sample wording that should be used to communicate risk in DTC ads: "Like all drugs, [drug name] has both benefits and risks. [Drug name] is only available by prescription, and your doctor can explain how [drug name] is likely to affect you. Be sure to tell your doctor about all of your medical conditions, and about any other medications you are taking, because this information could affect whether you should take [drug name]. Remember, only your doctor can decide if [drug name] is best for you."
This issue is discussed in more detail on Pharma Marketing Blog.
- Interactive Summary of Results (de-identified, excludes open-ended responses and comments that may identify the respondent). Allows you to use filters to examine results from different subsets of respondents (e.g., pharma company employees vs. non-pharma people, etc.)
| Subscribe |
|
A FREE monthly e-newsletter for pharma marketing professionals. Current Issue Order Reprints Subscribe Click Here
|
| Network |
|
Network with your peers in the industry, seek help advancing your career, discuss current issues. Learn More Lurk & Learn Join Click Here
|
| Advertise |
|
Pharma Marketing Network & Pharma Marketing News provide exceptional permission-based e-marketing opportunities. Learn More Media Kit Get Rate Card Click Here
|
| Get Listed |
|
A growing list of hundreds of pharmaceutical marketing services vendors, consultants, executive search firms, medical education companies, and other companies servicing the needs of pharmaceutical manufacturers. Learn More Access Listings Get a FREE Listing Click Here
|
| Meet |
|
Pharma Marketing News is proud to be a media partner for dozens of industry conferences. Conference Calendar Get Your Event Listed Click Here
|
| Find a Job |
|
Pharma Marketing Network accepts job listings relevant to the interests of our members and its members help colleagues find jobs. Job Listings Post Your Job Opening Click Here
|
| Learn More |
|
Pharma Marketing Network offers a wide range of other resources to help industry professionals keep up to date with pharma marketing techniques, best practices, issues and practical applications. Links Case Studies Glossary Surveys FAQs Blog Topics
|